Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Genitourinary 2

Conditions

Urinary Tract Infections 1Ureteral Obstruction 1Prostatic Neoplasms 1Neoplasms 1Infections 1Acute Kidney Injury 1

Interventions

Cyclophosphamide 548pembrolizumab 385Radiotherapy 363Bevacizumab 360Carboplatin 351Rituximab 315Cisplatin 300Gemcitabine 297Paclitaxel 288Dexamethasone 272Docetaxel 271fludarabine phosphate 241Doxorubicin 231Nivolumab 220Etoposide 209Cytarabine 203Lenalidomide 201fludarabine 191Oxaliplatin 191Fluorouracil 190Melphalan 189Filgrastim 188Capecitabine 175Calcium Dobesilate 172Radiosurgery 167Erlotinib Hydrochloride 167Methotrexate 163Bortezomib 162Granulocyte Colony-Stimulating Factor 154Whole-Body Irradiation 144

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Has results × Antibiotic Prophylaxis × Clear all
NCT06801405 2026-05-19

Antibiotic Prophylaxis in Percutaneous Nephrostomy Placements and Replacements for Malignant Urinary Tract Obstruction

Barretos Cancer Hospital

Completed
320 enrolled 6 charts
Genitourinary

Neoplasms, Ureteral Obstruction, Urinary Tract Infections, Acute Kidney Injury

NCT04843566 2025-04-15

PREVENT

Weill Medical College of Cornell University

Phase NA Completed
687 enrolled 11 charts
Genitourinary

Infections, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡